This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Columbia University, Masarykova Univerzita. Active years: 2014-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2026
Title: Vaclav Havel: Innovator in Therapeutics and Material Science
Introduction
Vaclav Havel is a notable inventor hailing from Opava, Czech Republic. He has made significant contributions to the fields of therapeutics and material science, holding a total of 2 patents. His work focuses on innovative solutions for neurological and psychiatric disorders, as well as advancements in material applications.
Latest Patents
Havel's latest patents include "Ibogaine analogs as therapeutics for neurological and psychiatric disorders." This invention provides a composition that comprises a compound which is a mixture of deuterium-containing and non-deuterium-containing molecules. Another significant patent is related to "Macrocyclic derivatives of glycolurils, and methods of preparing and using the same." This invention pertains to novel macrocyclic derivatives of glycolurils, which can be utilized for various applications such as water purification, separation of liquid mixtures, and drug targeting in organisms.
Career Highlights
Throughout his career, Vaclav Havel has worked with prestigious institutions, including Columbia University and Masarykova Univerzita. His research has led to advancements that bridge the gap between theoretical science and practical applications.
Collaborations
Havel has collaborated with notable individuals in his field, including Vladimir Sindelar and Jan Svec. These partnerships have contributed to the development of his innovative ideas and patents.
Conclusion
Vaclav Havel's contributions to the fields of therapeutics and material science highlight his role as a significant inventor. His patents reflect a commitment to addressing complex challenges in health and environmental sustainability.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
